441 related articles for article (PubMed ID: 17910890)
21. Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme.
Barbier N; Paul C; Luger T; Allen R; De Prost Y; Papp K; Eichenfield LF; Cherill R; Hanifin J
Br J Dermatol; 2004 Jan; 150(1):96-102. PubMed ID: 14746622
[TBL] [Abstract][Full Text] [Related]
22. Assessment of Intra- and Inter-Rater Reliability of Three Methods for Measuring Atopic Dermatitis Severity: EASI, Objective SCORAD, and IGA.
Bożek A; Reich A
Dermatology; 2017; 233(1):16-22. PubMed ID: 28494438
[TBL] [Abstract][Full Text] [Related]
23. Mild to moderate atopic dermatitis severity can be reliably assessed using smartphone-photographs taken by the patient at home: A validation study.
Ali Z; Chiriac A; Bjerre-Christensen T; Isberg AP; Dahiya P; Manole I; Dutei AM; Deaconescu I; Serban A; Suru A; Agner T; Kamstrup MR; Togsverd-Bo K; Zibert JR; Thomsen SF; Andersen AD
Skin Res Technol; 2022 Mar; 28(2):336-341. PubMed ID: 35020960
[TBL] [Abstract][Full Text] [Related]
24. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.
Eichenfield LF; Tom WL; Chamlin SL; Feldman SR; Hanifin JM; Simpson EL; Berger TG; Bergman JN; Cohen DE; Cooper KD; Cordoro KM; Davis DM; Krol A; Margolis DJ; Paller AS; Schwarzenberger K; Silverman RA; Williams HC; Elmets CA; Block J; Harrod CG; Smith Begolka W; Sidbury R
J Am Acad Dermatol; 2014 Feb; 70(2):338-51. PubMed ID: 24290431
[TBL] [Abstract][Full Text] [Related]
25. Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults.
Silverberg JI; Chiesa Fuxench ZC; Gelfand JM; Margolis DJ; Boguniewicz M; Fonacier L; Grayson MH; Simpson EL; Ong PY
Ann Allergy Asthma Immunol; 2018 Dec; 121(6):729-734.e4. PubMed ID: 30092267
[TBL] [Abstract][Full Text] [Related]
26. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group.
Hanifin JM; Thurston M; Omoto M; Cherill R; Tofte SJ; Graeber M
Exp Dermatol; 2001 Feb; 10(1):11-8. PubMed ID: 11168575
[TBL] [Abstract][Full Text] [Related]
27. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).
Chalmers JR; Simpson E; Apfelbacher CJ; Thomas KS; von Kobyletzki L; Schmitt J; Singh JA; Svensson Å; Williams HC; Abuabara K; Aoki V; Ardeleanu M; Awici-Rasmussen M; Barbarot S; Berents TL; Block J; Bragg A; Burton T; Bjerring Clemmensen KK; Creswell-Melville A; Dinesen M; Drucker A; Eckert L; Flohr C; Garg M; Gerbens LA; Graff AL; Hanifin J; Heinl D; Humphreys R; Ishii HA; Kataoka Y; Leshem YA; Marquort B; Massuel MA; Merhand S; Mizutani H; Murota H; Murrell DF; Nakahara T; Nasr I; Nograles K; Ohya Y; Osterloh I; Pander J; Prinsen C; Purkins L; Ridd M; Sach T; Schuttelaar ML; Shindo S; Smirnova J; Sulzer A; Synnøve Gjerde E; Takaoka R; Vestby Talmo H; Tauber M; Torchet F; Volke A; Wahlgren CF; Weidinger S; Weisshaar E; Wollenberg A; Yamaga K; Zhao CY; Spuls PI
Br J Dermatol; 2016 Jul; 175(1):69-79. PubMed ID: 27436240
[TBL] [Abstract][Full Text] [Related]
28. Validation of patient-reported global severity of atopic dermatitis in adults.
Vakharia PP; Chopra R; Sacotte R; Patel N; Immaneni S; White T; Kantor R; Hsu DY; Silverberg JI
Allergy; 2018 Feb; 73(2):451-458. PubMed ID: 28905999
[TBL] [Abstract][Full Text] [Related]
29. Validity and reliability of Patient-Reported Outcomes Measurement Information System Global Health scale in adults with atopic dermatitis.
Schwartzman G; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY; Silverberg JI
J Am Acad Dermatol; 2021 Sep; 85(3):636-644. PubMed ID: 33484762
[TBL] [Abstract][Full Text] [Related]
30. The Atopic Dermatitis Antecubital Severity score: validity, reliability, and sensitivity to change in patients with atopic dermatitis.
Baek JH; Park CW; Choi KM; Yang YS; Lee SY; Koh JS; Chung BY; Kim HO; Park GH
Int J Dermatol; 2015 Dec; 54(12):1382-9. PubMed ID: 25556325
[TBL] [Abstract][Full Text] [Related]
31. Do we need another symptom score for childhood eczema?
Hon KL; Kung JSC; Tsang KYC; Yu JWS; Cheng NS; Leung TF
J Dermatolog Treat; 2018 Aug; 29(5):510-514. PubMed ID: 28849683
[TBL] [Abstract][Full Text] [Related]
32. [Not Available].
Lacour JP
Ann Dermatol Venereol; 2020 Nov; 147(11S1):11S12-11S18. PubMed ID: 33250133
[TBL] [Abstract][Full Text] [Related]
33. Useful tools for the management of atopic dermatitis.
Ricci G; Dondi A; Patrizi A
Am J Clin Dermatol; 2009; 10(5):287-300. PubMed ID: 19658441
[TBL] [Abstract][Full Text] [Related]
34. IGAxBSA composite for assessing disease severity and response in patients with atopic dermatitis.
Paller AS; Tan JKL; Bagel J; Rossi AB; Shumel B; Zhang H; Abramova A
Br J Dermatol; 2022 Mar; 186(3):496-507. PubMed ID: 34726270
[TBL] [Abstract][Full Text] [Related]
35. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): a clinical outcome measure for the severity of atopic dermatitis.
Simpson EL; Bissonnette R; Paller AS; King B; Silverberg JI; Reich K; Thyssen JP; Doll H; Sun L; DeLozier AM; Nunes FP; Eichenfield LF
Br J Dermatol; 2022 Oct; 187(4):531-538. PubMed ID: 35442530
[TBL] [Abstract][Full Text] [Related]
36. Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitis.
Silverberg JI; Gelfand JM; Margolis DJ; Fonacier L; Boguniewicz M; Schwartz LB; Simpson E; Grayson MH; Ong PY; Fuxench ZCC
Ann Allergy Asthma Immunol; 2018 Oct; 121(4):464-468.e3. PubMed ID: 30003968
[TBL] [Abstract][Full Text] [Related]
37. The new scoring system for evaluation of skin inflammation extent and severity in patients with atopic dermatitis.
Silny W; Czarnecka-Operacz M; Silny P
Acta Dermatovenerol Croat; 2005; 13(4):219-24. PubMed ID: 16356394
[TBL] [Abstract][Full Text] [Related]
38. Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany.
Weisshaar E; Bentz P; Apfelbacher C; Haufe E; Heinrich L; Heratizadeh A; Abraham S; Harder I; Kleinheinz A; Wollenberg A; Schäkel K; Wiemers F; Ertner J; Augustin M; Wildberger J; Von Kiedrowski R; Worm M; Zink A; Effendy I; Asmussen A; Pawlak M; Sticherling M; Hilgers M; Handrick C; Quist S; Schwarz B; Bell M; Staubach-Renz P; Hong-Weldemann SH; Homey B; Brücher JJ; Weidinger S; Werfel T; Schmitt J;
Acta Derm Venereol; 2023 Jan; 103():adv00854. PubMed ID: 36688701
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal course and phenotypes of health-related quality of life in adults with atopic dermatitis.
Schwartzman G; Lei D; Ahmed A; Chavda R; Gabriel S; Silverberg JI
Clin Exp Dermatol; 2022 Feb; 47(2):359-372. PubMed ID: 34623642
[TBL] [Abstract][Full Text] [Related]
40. What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study.
Leshem YA; Hajar T; Hanifin JM; Simpson EL
Br J Dermatol; 2015; 172(5):1353-7. PubMed ID: 25580670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
